Streamlining MEDITECH Imfinzi Prior Authorization

Klivira automates the complex MEDITECH Imfinzi prior authorization process, integrating directly into your EMR to accelerate patient access to this critical oncology therapy.

For revenue cycle directors and prior authorization coordinators, managing high-volume, high-cost oncology medications like Imfinzi within the MEDITECH environment presents significant challenges. Delays in prior authorization directly impact patient care timelines and clinic revenue. Klivira streamlines this process, ensuring efficiency from order entry through approval.

Navigating Imfinzi Prior Authorization within MEDITECH

Imfinzi, an immune checkpoint inhibitor, frequently requires prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans. The process typically begins with an order within MEDITECH's Expanse, where clinicians initiate treatment plans. Klivira intercepts these orders, triggering an automated ePA workflow to gather necessary clinical documentation and submit to the payer.

MEDITECH Integration for Oncology ePA

Klivira leverages MEDITECH's modern integration surfaces, primarily FHIR R4 APIs and SMART App Launch capabilities available on Expanse, to embed prior authorization workflows directly into the clinical desktop. For legacy MEDITECH product lines (Magic, C/S, 6.x), we also support HL7 v2 interfaces for critical data exchange, ensuring comprehensive coverage across your health system's varied deployments.

Key Integration Points for Imfinzi PA Data Flow

Order Entry Capture: Automatically detect Imfinzi orders placed in MEDITECH, initiating the prior authorization request.
Clinical Data Extraction: Utilize FHIR R4 read APIs to pull US Core resources from Expanse, including patient demographics, diagnoses, and relevant clinical notes.
SMART on FHIR Launch: Provide a context-aware launch point from the MEDITECH Expanse clinical desktop for PA coordinators to review and manage Imfinzi cases.
Status Write-back: Update the MEDITECH patient chart with real-time prior authorization status, leveraging available write APIs for DocumentReference or Communication resources.
Documentation Deposit: Upload payer-required documentation and approval letters as attachments within MEDITECH's documentation modules.

Medical vs. Pharmacy Benefit for Imfinzi

Imfinzi is typically administered in an outpatient setting, falling under the medical benefit and requiring a medical prior authorization. Klivira's platform is designed to manage these complex medical benefit PAs, differentiating them from pharmacy benefit medications processed via NCPDP SCRIPT. This distinction is crucial for accurate submission via X12 278 transactions or payer portals.

Enhancing Documentation for Imfinzi Prior Authorizations

Successful Imfinzi prior authorizations depend on robust clinical documentation. Klivira's platform intelligently extracts critical information from MEDITECH's patient summary, documentation modules, and problem lists. This includes diagnosis codes, treatment history, lab results, and physician notes, ensuring the submitted PA packet is comprehensive and aligns with payer medical policies and guidelines.

Streamlining Specialty Pharmacy Routing

Once Imfinzi prior authorization is secured, seamless coordination with specialty pharmacies is essential. Klivira integrates with MEDITECH's orders activity and communication workflows to facilitate the accurate and timely routing of prescriptions and necessary clinical data to the designated specialty pharmacy, minimizing delays in medication dispensing.

Frequently asked questions

How does MEDITECH's product line variability impact Imfinzi prior authorization automation?

MEDITECH's integration capabilities vary significantly between Expanse and legacy product lines like Magic, C/S, or 6.x. Klivira's solution adapts by leveraging modern FHIR R4 and SMART App Launch for Expanse, while also supporting HL7 v2 interfaces for older deployments to ensure consistent Imfinzi PA workflows across your entire MEDITECH footprint.

What specific data does Klivira pull from MEDITECH for Imfinzi prior authorizations?

Klivira extracts essential clinical data from MEDITECH to support Imfinzi PAs. This includes patient demographics, diagnosis codes, active problem lists, relevant lab results, and clinical notes from the patient summary and documentation modules, all pulled via secure FHIR R4 APIs or HL7 v2 interfaces depending on your MEDITECH environment.

How does Klivira handle the distinction between medical and pharmacy benefit PAs for Imfinzi?

Imfinzi is typically covered under the medical benefit. Klivira's platform is designed to manage medical benefit prior authorizations, which often involve X12 278 transactions or payer portal submissions, distinct from pharmacy benefit PAs processed via NCPDP SCRIPT. We ensure the correct channel and data elements are used for each Imfinzi request.

Can Klivira update the Imfinzi prior authorization status directly within MEDITECH?

Yes, Klivira aims to write back prior authorization status updates directly into the MEDITECH patient chart. This typically involves leveraging available FHIR write APIs on Expanse for resources like DocumentReference or Communication, ensuring PA coordinators and clinicians have real-time visibility into the Imfinzi approval process. Specific write capabilities are verified per customer.

Does Klivira facilitate specialty pharmacy referrals for Imfinzi from MEDITECH?

Klivira streamlines the post-authorization process by integrating with MEDITECH's orders activity and communication workflows. This enables efficient routing of Imfinzi prescriptions and necessary clinical information to the designated specialty pharmacy, helping to prevent delays in medication fulfillment after PA approval.